Lamictal News
Effectiveness and Weight Effects of Open-Label Lamotrigine - Medscape (subscription)
Bowden CL, Calabrese JR, Sachs G, et al, and the Lamictal 606 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance ...
Epilepsy Drug Can Increase Risk for Newborns, Study Says - New York Times
An estimated 24 million American women have taken these drugs — which include Tegretol from Novartis, Lamictal from GlaxoSmithKline and Dilantin from Parke ...
Exposure to Epilepsy Drug During Pregnancy Can Increase Risk of ... - MedIndia
The mothers of the children had taken either Depakote, GlaxoSmithKline's Lamictal, Novartis' Tegretorl or Parke-Davis' Dilanten. ...
Lamictal effective in treating patients with partial seizures - SpiritIndia
Lamictal XR Extended-Release Tablets are currently in development for the treatment of epilepsy. If approved, it will be the first extended release, ...
Exposure to Epilepsy Drug Depakote During Pregnancy Can Increase ... - Kaiser network.org
The mothers of the children had taken either Depakote, GlaxoSmithKline's Lamictal, Novartis' Tegretorl or Parke-Davis' Dilanten (Carey, New York Times ...
GSK hit by strong sterling but underlying growth is good - Pharma Times (subscription)
Sales of Lamictal (lamotrigine) for epilepsy were up 17% to £250 million, while heart disease drug Coreg (carvedilol) increased 8% to £217 million. ...
New Data Shows Once a Day Lamictal XR is Effective in Treating ... - PharmaLive.com (press release)
Lamictal XR Extended- Release Tablets are currently in development for the treatment of epilepsy. If approved, it will be the first extended release, ...
Lamictal RSS Feed